欧美娜红蓝光治疗痤疮的疗效观察及护理

目的探讨欧美娜红蓝光治疗痤疮患者的临床效果及护理方法。方法对我院门诊86例痤疮患者在常规药物治疗的基础上,给予欧美娜红蓝光交替照射面部治疗,治疗4周后观察疗效,同时在治疗过程中实施心理疏导、皮肤护理、饮食指导、光疗护理等干预措施。结果全部患者治疗依从性好,治疗有效率为82.6%。结论欧美娜红蓝光治疗痤疮的疗效好,不良反应轻,结合细致的护理措施可提高疗效,缩短疗程,改善患者的生活质量。     

中药泡浴联合苗药内服治疗寻常型银屑病的临床研究

目的探讨中药泡浴联合苗药内服治疗寻常型银屑病的临床疗效及安全性。方法选取广西皮肤病医院及广西瑞康医院2014年10月~2017年10月收治的300例寻常型银屑病患者为研究对象,按随机数字表法分为治疗组和对照组各150例,对照组给予单纯苗药内服治疗,治疗组在苗药内服基础上联合中药泡浴治疗,两组均连续治疗6周,观察记录两组患者治疗3周、6周时的银屑病面积和严重程度指数(PASI评分)、临床总有效率、皮肤病生活质量量表(DLQI评分),并进行比较。结果两组患者治疗3周、6周时的PASI评分较治疗前显著下降(均P0.05),且治疗组的下降幅度明显优于对照组(均P0.05)。治疗组治疗3周、6周时的总有效率均明显高于对照组,差异均有统计学意义(均P0.05)。两组患者治疗前的DLQI评分比较无显著性差异(P0.05),治疗3周、6周后,治疗组的DLQI评分明显低于对照组(均P0.05);而且治疗6周时,治疗组的PASI评分、DLQI评分下降明显,与对照组比较差异有显著性意义(均P0.05)。两组患者的临床总有效率比较,治疗组明显高于对照组(P0.05),而且两组治疗期间均未发生治疗不耐受的不良反应。结论采用中药泡浴联合苗药内服治疗寻常型银屑病的疗效果显著,可有效缓解患者的临床症状及体征,促进皮损消退,进一步提高治疗效果,改善患者生活质量及临床预后,具有一定临床应用价值。     

封包联合窄波UVB治疗寻常型银屑病疗效观察及护理体会

目的:探讨封包联合窄波UVB治疗寻常型银屑病疗效及护理方法。方法:自2010年2月至2011年8月到我院治疗的142例寻常型银屑病患者分为两组,治疗组予封包联合窄波UVB治疗并配合精心护理,对照组仅予封包治疗,两组均在治疗6周后观察症状及体征的变化。患者治疗后随访半年。结果:治疗组较对照组第4周PASI评分(4.33±3.23 vs 6.24±3.35)和第6周PASI评分(2.32±2.02 vs 3.68±2.52)明显降低,有统计学差异(P<0.05)。治疗组与对照组有效率分别为85.89%和67.19%,差异有显著统计学意义(P<0.01)。随访半年结果治疗组复发率较对照组少(P<0.05)。结论:封包联合窄波UVB治疗寻常型银屑病并配合精心护理能够取得良好的临床治疗效果。     

重组牛碱性成纤维细胞生长因子凝胶治疗寻常痤疮的临床观察

目的评价重组牛碱性成纤维细胞生长因子凝胶治疗寻常痤疮的临床疗效及安全性。方法将纳入的60例Ⅰ、Ⅱ、Ⅲ级面部痤疮患者随机分为两组,每组各30例,观察组予重组牛碱性成纤维细胞生长因子凝胶外用治疗,对照组予阿达帕林凝胶外用治疗,共治疗8周,观察比较两组治疗前后皮损计数、临床疗效及不良反应发生率。结果治疗组总有效率为73.33%,与对照组的83.33%比较,差异无统计学意义(P0.05)。治疗后,两组患者的皮损计数均高于治疗前,差异有统计学意义(P0.05);治疗后,两组皮损计数比较差异无统计学意义(P0.05)。对照组的不良反应发生率为26.67%明显高于治疗组的3.33%,差异有统计学意义(P0.05)。结论重组牛碱性成纤维细胞生长因子凝胶治疗轻、中度痤疮的疗效好,安全性高。     

薛氏4号方联合苯磺酸氨氯地平片治疗湿热侵络型高血压的疗效及对血脂和血液流变学的影响

摘要 目的：观察湿热侵络型高血压患者经苯磺酸氨氯地平片联合薛氏4号方治疗后的疗效及其对血脂和血液流变学的影响。方法：采用随机数字表法将2020年1月~2022年12月期间石家庄市中医院收治的120例湿热侵络型高血压患者分为对照组（n=60,苯磺酸氨氯地平片治疗）及联合组（n=60,对照组基础上接受薛氏4号方治疗）。观察两组治疗4周后的临床疗效,对比两组治疗前、治疗4周后的血压、中医证候积分、血脂和血液流变学情况。结果：联合组的临床总有效率高于对照组（P<0.05）。联合组治疗4周后收缩压（SBP）、舒张压（DBP）低于对照组（P<0.05）。联合组治疗4周后眩晕、头痛、口渴少饮、肢体困重、失眠、心悸、胸闷、肢体麻木中医证候积分低于对照组（P<0.05）。联合组治疗4周后甘油三酯（TG）、总胆固醇（TC）、低密度脂蛋白胆固醇（LDL-C）低于对照组,高密度脂蛋白胆固醇（HDL-C）高于对照组（P<0.05）。联合组治疗4周后红细胞聚集指数、血小板最大聚集率、全血高切黏度、全血低切黏度低于对照组（P<0.05）。结论：薛氏4号方联合苯磺酸氨氯地平片治疗湿热侵络型高血压,可提高临床疗效,降低血压,降低中医证候积分,改善血脂和血液流变学。     

祛癣止痒洗液联合硝酸咪康唑乳膏治疗角化型足癣疗效观察

目的：观察祛癣止痒洗液联合硝酸咪康唑乳膏治疗角化型足癣疗效。方法全部患者随机分成两组,治疗组100例,对照组100例。治疗组用祛癣止痒洗液泡脚,1袋／次,2次／d,泡脚后外涂硝酸咪康唑乳膏;对照组用硝酸咪康唑乳膏外涂,2次／d,两组疗程均为4周,4周后进行临床疗效及真菌学疗效评价。结果治疗4周时,治疗组总有效率80％,对照组总有效率62％。两组比较有显著性差异（P＜0．05）。结论祛癣止痒洗液联合硝酸咪康唑乳膏治疗角化型足癣,疗效肯定,值得临床推广应用。     

胃苏颗粒联合四联疗法对幽门螺杆菌相关性消化性溃疡患者血清炎性因子、胃肠激素及生活质量的影响

摘要 目的：探讨胃苏颗粒联合四联疗法对幽门螺杆菌（Hp）相关性消化性溃疡患者血清炎性因子、胃肠激素及生活质量的影响。方法：选取2018年3月~2019年12月期间我院收治的Hp阳性消化性溃疡患者124例,根据奇偶数字法将患者分为对照组、联合组,各62例。对照组给予四联疗法,联合组给予胃苏颗粒联合四联疗法,疗程均为4周。对比两组疗效、Hp根除率、炎性因子水平、胃肠激素水平、生活质量及不良反应。结果：联合组Hp根除率、临床总有效率高于对照组（P<0.05）。联合组治疗4周后SF-36量表各维度评分较对照组更高（P<0.05）。联合组治疗4周后血清降钙素原（PCT）、白介素-6（IL-6）、超敏C反应蛋白（hs-CRP）水平低于对照组（P<0.05）。联合组治疗4周后胃泌素（GAS）、胃动素（MTL）低于对照组（P<0.05）。两组不良反应发生率对比差异无统计学意义（P>0.05）。结论：胃苏颗粒联合四联疗法治疗Hp相关性消化性溃疡患者,可有效改善患者体内血清炎性因子及胃肠激素水平,并提高其生活质量和Hp根除率,疗效优于单纯四联疗法。     

重组人表皮生长因子联合光子嫩肤M22对痤疮凹陷性瘢痕患者皮肤屏障功能的影响

摘要 目的：探讨与分析重组人表皮生长因子联合光子嫩肤M22对痤疮凹陷性瘢痕患者皮肤屏障功能的影响。方法：2020年9月到2022年2月选择在本院诊治的痤疮凹陷性瘢痕患者120例作为研究对象,根据1:1简单分配原则把患者分为联合组与对照组各60例。对照组给予重组人表皮生长因子治疗,联合组在对照组治疗的基础上给予光子嫩肤M22治疗,两组都治疗观察4周。结果：治疗后联合组的总有效率为88.3 %,高于对照组的66.7 %（P<0.05）。联合组的红斑消退时间等临床症状较对照组少（P<0.05）。两组治疗后皮肤油脂比例低于治疗前,皮肤含量水高于治疗前,治疗后联合组的皮肤油脂比例、含水量与对照组对比有差异（P<0.05）。两组治疗后的瘢痕基底深度较治疗前低,联合组较对照组低（P<0.05）。治疗后,两组主观、客观美学评分较治疗前高,联合组较对照组高（P<0.05）。结论：重组人表皮生长因子联合光子嫩肤M22在痤疮凹陷性瘢痕患者的能改善皮肤屏障功能,能降低瘢痕基底深度与皮肤油脂比例,提高皮肤含水量,能促进改善临床症状,提高皮肤的美学评分,从而提高总体治疗效果。     

钙泊三醇倍他米松软膏联合NB-UVB对掌跖脓疱病患者 血清TNF-alpha, IL-17水平的影响

目的：观察钙泊三醇倍他米松软膏联合窄谱中波紫外线(NB-UVB)治疗掌跖脓疱病的临床疗效及对患者血清肿瘤坏死因子 -alpha(TNF-alpha)、白细胞介素-17(IL-17)水平的影响。方法：选取掌跖脓疱病患者63 例,随机分为治疗组和对照组,治疗组外用钙泊三醇 倍他米松软膏联合NB-UVB 治疗,对照组单纯照射NB-UVB,两组患者的疗程均为8 周,治疗4 周及8 周后观察临床疗效,并测 定血清中TNF-琢、IL-17 的浓度。结果：治疗4周和8 周后,治疗组症状积分较对照组明显下降,差异有统计学意义(P<0.05);治疗4 和8 周时,对照组的有效率分别为22.58 %和45.16 %,治疗组为53.13 %和78.13 %,两组患者的有效率比较差异显著(P<0.05);停 药后3 个月,对照组复发率为35.48 %,治疗组复发率为12.50 %,治疗组明显低于对照组;治疗后两组患者血清中TNF-alpha、IL-17 的浓度均较前下降,且治疗组较对照组下降更明显,差异具有统计学意义(P<0.05)。结论：钙泊三醇倍他米松软膏辅助治疗可以更 有效提高掌跖脓疱病患者的临床疗效,且安全性较好,这可能与其降低患者外周血中TNF-琢和IL-17 的水平有关。     

氯吡格雷联合阿司匹林治疗老年冠心病的临床疗效观察

目的：探讨氯吡格雷联合阿司匹林治疗老年冠心病（CHD）的临床疗效和安全性。方法：60例老年CHD患者随机分为治疗组和对照组。对照组采用阿司匹林治疗,治疗组采用氯吡格雷联合阿司匹林治疗,治疗4周后观察血小板聚集率（PAG）和凝血功能。结果：治疗4周后,治疗组PAG显著下降,APTT显著上升,与治疗前和对照组比较均有显著性差异（P〈0.05）;两组治疗前后PT、PA变化差异无统计学意义（P〉0.05）。两组均未出现不良反应。结论：阿斯匹林联合氯吡格雷治疗老年CHD患者,较单用阿斯匹林治疗更能有效地抑制血小板聚集和预防血栓形成,并能得到更好的临床疗效。     

黄瓜香等中草药对寻常型痤疮治疗效果的观察

目的应用黄瓜香等中草药作为微生态调节剂治疗青少年寻常型痤疮。方法通过比较治疗前后痤疮患者面部皮肤痤疮丙酸杆菌和表皮葡萄球菌数量以及面部皮疹的数量来判断黄瓜香等中草药治疗痤疮的疗效。结果黄瓜香抑制了痤疮丙酸杆菌和表皮葡萄球菌生长（P〈0．05）;减少了皮疹数量（P〈0．05）,使皮疹不再出现。结论黄瓜香等能够治疗青少年寻常型痤疮。     

Effect of vaccination therapy for acne,using a staphylococci antigenic complex in combination with clindamycin

A group of 46 patients with acne vulgaris were prescribed clindamycin in combination with a vaccination therapy using a staphylococci antigenic complex (Polystafana; Sevapharma, Czechia). Acne papulopustulosa was diagnosed in 36 patients and acne indurata in 10 patients. The clinical effect of clindamycin and Polystafana was determined on the basis of the regression of the inflammatory manifestation of acne: regression by 0-30% was considered unsuccessful, by 30-80% satisfactory, and above 80% excellent; the immunomodulation effect of the treatment was evaluated in parallel. The clinical effect was excellent in 21 patients with acne papulopustulosa and in 6 with acne indurata; it was accompanied by pronounced immunomodulation effect as both cellular and humoral immunity was also tended to return to normal values. A satisfactory clinical effect was observed in 15 patients with acne papulopustulosa, whose cellular immunity component was also stimulated. Only 4 patients with acne indurata failed to respond successfully. These were the patients who showed a pronounced deficit of the cellular immunity component persisting even after the treatment. The administration of clindamycin in combination with Polystafana vaccination can be recommended as an effective means for the treatment of acne vulgaris.     

清热解毒祛风中药治疗口腔扁平苔癣的临床疗效及对患者外周血T淋巴细胞亚群的影响观察

目的：探讨养血解毒祛风中药治疗40例口腔扁平苔藓的临床疗效以及其对OLP患者外周血T淋巴细胞亚群的影响。方法：将80例扁平苔癣患者随机分为中药组40例和西药对照组40例。治疗组采用中药养血解毒祛风法辨证施治,对照组患者以西药治疗,用左旋咪唑50mg／次,3次／d,口服3天停4天一个月。结果：治疗组与对照组统计学上有显著性差异,中药治疗对患者T细胞亚群有很好的调节作用。结论：中药清热解毒祛风治疗口腔扁平苔癣有显著疗效。     

Anti-inflammatory activity of cationic peptides: application to the treatment of acne vulgaris

Cationic antimicrobial peptides exhibit potent antimicrobial activity against clinically relevant microorganisms including Propionibacterium acnes. Recent studies showed that, in addition to the antimicrobial activity, these peptides can exhibit an anti-inflammatory effect. These properties make cationic peptides attractive drug candidates for the treatment of acne vulgaris, a disease with both bacterial and inflammatory components. This review focuses on the anti-inflammatory activity of cationic antimicrobial peptides and its application for the treatment of acne vulgaris. The anti-inflammatory activity of cationic peptides in acne vulgaris can be explained by their ability to both bind proinflammatory bacterial factors (e.g. lipoteichoic acid), sequestering them from the site of inflammation, and to inhibit the secretion of proinflammatory cytokines (e.g. tumor necrosis factor-alpha, IL-1) by host cells. These anti-inflammatory effects combined with potent antimicrobial activity may translate into a novel therapeutic option for acne vulgaris.     

Oxidative stress in patients with acne vulgaris

Acne vulgaris is one of the common dermatological diseases and its pathogenesis is multifactorial. In this study, we aim to determine the effects of oxidative stress in acne vulgaris. Forty-three consecutive acne patients and 46 controls were enrolled. The parameters of oxidative stress such as catalase (CAT), glucose-6-phosphate dehydrogenase (G6PD), superoxide dismutase (SOD), and malondialdehyde (MDA) in the venous blood of cases were measured spectrophotometrically. The values compared with control group, the relation between the severity and distribution of acne, and the correlation of each enzyme level were researched. CAT and G6PD levels in patients were found to be statistically decreased, and SOD and MDA levels were found to be statistically increased (P < .001). However, any statistical difference and correlation could not be found between the severity and distribution of lesions and the mean levels of enzymes. In addition, we found that each enzyme is correlated with one another. Our findings show that oxidative stress exists in the acne patients. It will be useful to apply at least one antioxidant featured drug along with the combined acne treatment.     

Acne: double blind clinical and laboratory trial of tetracycline,oestrogen-cyproterone acetate,and combined treatment.

Since the recent introduction of a drug regimen containing 2 mg of the antiandrogen cyproterone acetate and 50 micrograms ethinyl-oestradiol (Diane; oestrogen-cyproterone acetate) several uncontrolled reports have extolled the benefits of this drug. Double blind studies, however, are lacking. Sixty two patients with moderate or moderately severe acne were therefore included in a double blind trial of treatment for six months comparing tetracycline alone, oestrogen-cyproterone acetate alone, and a combination of these agents. Sebum excretion rates and bacterial counts were measured before, during, and after treatment, at the same time as a clinical assessment was made. At six months the acne (as assessed by overall grade) had improved by 68% in the antibiotic treated group and by 74% in the oestrogen-cyproterone treated group. The group given a combination of both agents improved by 82%, which was significantly better (p less than 0.025) than the improvement in the tetracycline treated patients. No significant difference was found between the groups given oestrogen-cyproterone alone and the combined treatment. The sebum excretion rate was suppressed by 25% in the patients in both groups receiving oestrogen-cyproterone but not in the group given antibiotics alone. Oestrogen-cyproterone acetate is as effective as antibiotics in treating acne in women, and adding antibiotics offers no advantage over using oestrogen-cyproterone on its own, although in this study the combination was more effective than tetracycline alone at six months.     

参苓白术散联合沙美特罗治疗COPD的临床疗效分析

目的：探讨参苓白术散结合沙美特罗治疗对慢性阻塞性肺疾病（COPD）的临床疗效。方法：采用前瞻性随机对照设计。将93例COPD患者随机均分为三组（称为A、B、C组）,A组给予中药参苓白术散口服和沙美特罗喷雾剂吸入治疗,B组给予中药参苓白术散颗粒剂口服治疗,C组给予沙美特罗喷雾剂吸入治疗,治疗疗程3个月,观察治疗前后三组患者的临床症状和体征、中医症状评分以及肺功能包括FEV1、FVC和PEF变化情况。结果：治疗3个月后,给予中药参苓白术散剂口服和沙美特罗喷雾剂吸入治疗的A组患者临床症状和体征、中医症状评分以及肺功能较治疗前明显改善,FEV1和FVC分别提高了0-3L和0-37L,PEF也增加了44L／min,并且这两种药物联合治疗疗效也明显优于B、c组（P〈0．05）。结论：参苓白术散结合沙关特罗治疗能明显改善COPD患者临床表现和肺功能。     

Cyproterone acetate treatment of females with hyperandrogenism

Five females with idiopathic hirsutism, ten with adrenogenital syndrome, four with acne vulgaris, and three with Stein-Leventhal syndrome were treated for nine months with large or small doses of cyproterone acetate (100 or 2 mg daily, respectively) in combination with oestrogen. The drug had a good effect on the acne vulgaris and moderated the hirsutism. In the various patient groups the serum testosterone level was decreased to between 58.6% (+/- 28.7% S.E.) and 10.8% (+/- 8.2% S.E.) of the basal value. No essential difference in effectiveness was observed between the large and small doses. Based on study of the side-effects, it is recommended that laboratory liver tests are used for control.     

Taurine bromamine (TauBr) - its role in immunity and new perspectives for clinical use

This review is an attempt to summarize our knowledge about taurine bromamine (TauBr) properties, its role in innate immunity and its therapeutic potential.TauBr and taurine chloramine (TauCl) are major haloamines generated by eosinophils and neutrophils at a site of inflammation. Both haloamines share anti-inflammatory and anti-oxidant properties. TauBr, similarly to TauCl, decreases the production of proinflammatory mediators. Their anti-inflammatory and anti-oxidant activities are enhanced by their ability to induce the expression of heme oxygenase-1 (HO-1). TauCl is more stable than TauBr. On the other hand, only TauBr was found to be highly membrane-permeable showing stronger microbicidal activity than TauCl.In the light of the anti-inflammatory and antimicrobial properties of TauBr we discuss its therapeutic potential in local treatment of inflammation, especially acne vulgaris, the most common inflammatory skin disorder. TauBr, at non-cytotoxic concentrations, is able to kill Propionibacterium acnes, the skin bacteria involved in pathogenesis of acne vulgaris.As topical antibiotics used in the therapy of acne are associated with the emergence of resistant bacteria, topical TauBr seems to be a good candidate for an alternative therapy.Recently, in a double blind trial, the efficacy of TauBr was compared with the efficacy of clindamycin, one of the most common topical antibiotics used in acne therapy. Comparable reduction of acne lesions was observed in the TauBr and clindamycin groups of patients with mild and moderate inflammatory facial acne vulgaris. We conclude that this pilot study supports our concept that TauBr can be used as a topical agent in the treatment of acne vulgaris, especially in patients who have already developed antibiotic resistance. Further studies are necessary to substantiate the more extended use of TauBr as an anti-inflammatory and anti-oxidant agent in human medicine.